We updated the design of this site on December 18, 2017. Learn more.
ClinicalTrials.gov
ClinicalTrials.gov Menu

Coronary Artery Risk Development in Young Adults (CARDIA)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00005130
Recruitment Status : Completed
First Posted : May 26, 2000
Last Update Posted : April 14, 2016
Sponsor:
Information provided by:
National Heart, Lung, and Blood Institute (NHLBI)

Brief Summary:
To measure changes in coronary heart disease risk factors in cohorts of Black and white males and females 18 to 30 years of age at baseline. Also, to identify life styles during this age span which influence these changes in risk factors.

Condition or disease
Cardiovascular Diseases Coronary Disease Hypertension Heart Diseases Obesity Diabetes Mellitus

  Show Detailed Description

Study Type : Observational
Observational Model: Cohort
Time Perspective: Prospective
Study Start Date : January 1984
Primary Completion Date : September 2008
Study Completion Date : September 2008




Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   Child, Adult, Senior
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population
Black and white males and females 18 to 30 years of age at baseline.
Criteria
No eligibility criteria

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00005130


Sponsors and Collaborators
National Heart, Lung, and Blood Institute (NHLBI)
Investigators
Principal Investigator: Jeffrey Carr Wake Forest University Health Sciences
Principal Investigator: Robert Detrano Harbor-UCLA Research and Development Institute
Principal Investigator: Cora Lewis University of Alabama at Birmingham
Principal Investigator: Kiang Liu Northwestern University
Principal Investigator: Daniel O'Leary Tufts Medical Center
Principal Investigator: Pamela Schreiner University of Minnesota - Clinical and Translational Science Institute
Principal Investigator: Stephen Sidney Kaiser Foundation Research Institute
Principal Investigator: O. Williams University of Alabama at Birmingham
Principal Investigator: Nathan Wong University of California at Irvine

Additional Information:
Publications:
For a bibliography see http://www.cardia.dopm.uab.edu/

Study Data/Documents: Individual Participant Data Set  This link exits the ClinicalTrials.gov site
Identifier: CARDIA
NHLBI provides controlled access to IPD through BioLINCC. Access requires registration, evidence of local IRB approval or certification of exemption from IRB review, and completion of a data use agreement.

Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):

ClinicalTrials.gov Identifier: NCT00005130     History of Changes
Other Study ID Numbers: 1000
First Posted: May 26, 2000    Key Record Dates
Last Update Posted: April 14, 2016
Last Verified: April 2009

Additional relevant MeSH terms:
Diabetes Mellitus
Cardiovascular Diseases
Heart Diseases
Coronary Disease
Coronary Artery Disease
Glucose Metabolism Disorders
Metabolic Diseases
Endocrine System Diseases
Myocardial Ischemia
Vascular Diseases
Arteriosclerosis
Arterial Occlusive Diseases